Bio-Rad Laboratories (BIO) Share-based Compensation (2009 - 2025)
Bio-Rad Laboratories (BIO) posted quarterly Share-based Compensation of $400000.0 for Q4 2025, up 100.94% year-over-year from $199063.2 in Q4 2024, and up 101.63% quarter-over-quarter from -$24.6 million in Q3 2025.
Bio-Rad Laboratories (BIO) Share-based Compensation (2009 - 2025) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Share-based Compensation for 17 consecutive years, with $400000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Share-based Compensation rose 100.94% year-over-year to $400000.0; the TTM figure through Dec 2025 stood at -$51.1 million (down 315.04% YoY), while the FY2025 annual figure was $3.0 million, down 11.76% from the prior year.
- Share-based Compensation climbed to $400000.0 in Q4 2025 per BIO's latest filing, from -$24.6 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $44.8 million in Q3 2023 and bottomed at -$42.5 million in Q4 2024.
- Historically, Share-based Compensation has averaged -$2142.9 across 5 years, with a median of $262000.0 in 2022.
- On a YoY basis, Share-based Compensation climbed as much as 438.69% in 2023 and fell as far as 24454.84% in 2023.
- Bio-Rad Laboratories' Share-based Compensation stood at -$13.7 million in 2021, then surged by 100.9% to $124000.0 in 2022, then plunged by 24454.84% to -$30.2 million in 2023, then slumped by 40.73% to -$42.5 million in 2024, then jumped by 100.94% to $400000.0 in 2025.
- Business Quant data shows BIO's Share-based Compensation at $400000.0 in Q4 2025, -$24.6 million in Q3 2025, and -$42.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | -24.60 Mn |
| Sep 30, 2025 | -24.60 Mn |
| Dec 31, 2024 | -42.50 Mn |
| Dec 31, 2024 | -42.50 Mn |
| Sep 30, 2024 | 15.60 Mn |
| Sep 30, 2024 | 15.60 Mn |
| Dec 31, 2023 | -30.20 Mn |
| Dec 31, 2023 | -30.20 Mn |
| Sep 30, 2023 | 44.79 Mn |
| Sep 30, 2023 | 44.79 Mn |
| Dec 31, 2022 | 124,000.00 |
| Dec 31, 2022 | 124,000.00 |
| Sep 30, 2022 | -13.22 Mn |
| Sep 30, 2022 | -13.22 Mn |
| Jun 30, 2022 | 13.60 Mn |
| Jun 30, 2022 | 13.60 Mn |
| Mar 31, 2022 | 13.50 Mn |
| Mar 31, 2022 | 13.50 Mn |